0001055726-23-000007.txt : 20230228 0001055726-23-000007.hdr.sgml : 20230228 20230228174425 ACCESSION NUMBER: 0001055726-23-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230226 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shea Jacqueline Elizabeth CENTRAL INDEX KEY: 0001771498 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14888 FILM NUMBER: 23687836 MAIL ADDRESS: STREET 1: C/O INOVIO PHARMACEUTICALS, INC. STREET 2: 660 W. GERMANTOWN PIKE, SUITE 110 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330969592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 4 1 wf-form4_167762425136925.xml FORM 4 X0306 4 2023-02-26 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001771498 Shea Jacqueline Elizabeth 660 W. GERMANTOWN PIKE PLYMOUTH MEETING PA 19462 1 1 0 0 Chief Executive Officer Common Stock 2023-02-26 4 M 0 22544 A 99099 D Common Stock 2023-02-26 4 F 0 9788 1.28 D 89311 D Common Stock 2023-02-26 4 M 0 70234 A 159545 D Common Stock 2023-02-26 4 F 0 32485 1.28 D 127060 D Restricted Stock Unit 2023-02-26 4 M 0 22544 0 D Common Stock 22544.0 22544 D Restricted Stock Unit 2023-02-26 4 M 0 70234 0 D Common Stock 70234.0 140466 D Common Stock Option 1.24 2023-02-27 4 A 0 836800 0 A 2023-02-27 2033-02-27 Common Stock 836800.0 836800 D Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein. Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 210,700 restricted stock units, vesting as follows: 70,234 shares vested on February 26, 2023; 70,233 shares will vest on February 26, 2024; and 70,233 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein. The vesting schedule for the 836,800 options is as follows: 209,200 shares vested on February 27, 2023; 209,200 shares will vest on February 26, 2024; 209,200 shares will vest on February 26, 2025; and 209,200 shares will vest on February 26, 2026. /s/ Jacqueline E. Shea 2023-02-28